title: Transplantation for liver failure in patients with sickle cell disease: challenging but feasible.
abstract: Sickle cell disease (SCD) frequently affects the liver; if acute liver failure (ALF) develops, the only potentially effective therapeutic option is liver transplantation (LT). Only 12 patients for whom LT was performed for SCD-related ALF have been described so far. We report a retrospective series of 6 adult patients with SCD (3 men and 3 women, median age = 40.1 years) who underwent emergency LT. The indication for LT was ALF complicating cirrhosis in 5 patients (hepatitis C/iron overload-induced cirrhosis in 3 and iron overload-induced cirrhosis in 2); one patient had autoimmune hepatitis. The median follow-up was 52.7 months (0.5-123 months). The 1-, 3-, 5-, and 10-year survival rates were 83.3%, 66.7%, 44.4%, and 44.4%, respectively. One patient died of hepatocellular failure precipitated by hyperacute allograft rejection on post-LT day 10. Soon after LT, 2 patients developed seizures; in 1 case, the seizures were a complication of early calcineurin inhibitor-induced leukoencephalopathy. Four long-term survivors benefited from specific management of SCD; specifically, the hemoglobin S fraction was maintained below 30% and the total hemoglobin level was maintained between 8 and 10 g/dL. Two patients had mild vaso-occlusive crises. Three patients experienced a recurrence of hepatitis C virus (HCV) infection; 2 of these patients experienced reversible neurological complications while they were receiving antiviral treatment. Carefully selected patients with SCD may benefit from emergency LT. However, such patients seem to be particularly susceptible to neurological complications after LT. In contrast, severe SCD-related crises do not seem to recur if specific management is provided. Outcomes may be improved if the neurological complications can be minimized; for example, the administration of a calcineurin inhibitor can be delayed, and the management of HCV infection recurrence can be improved.
authors: Service d'Hépatologie, Université Paris XII Val de Marne-France, Créteil, France. monika.hurtova@hmn.aphp.fr
authors: Monika
authors: M
authors: Hurtova
authors: Dora
authors: D
authors: Bachir
authors: Ketty
authors: K
authors: Lee
authors: Julien
authors: J
authors: Calderaro
authors: Thomas
authors: T
authors: Decaens
authors: Michael D
authors: MD
authors: Kluger
authors: Elie Serge
authors: ES
authors: Zafrani
authors: Daniel
authors: D
authors: Cherqui
authors: Ariane
authors: A
authors: Mallat
authors: Frédéric
authors: F
authors: Galactéros
authors: Christophe
authors: C
authors: Duvoux
mesh_terms: D000328:Adult; D000755:Anemia, Sickle Cell / Q000150:complications*; D005260:Female; D006801:Humans; D008099:Liver / Q000473:pathology; D017114:Liver Failure, Acute / Q000150:complications / Q000601:surgery*; D016031:Liver Transplantation; D008297:Male; D008875:Middle Aged